Using flow cytometry, fluorescent microscopy and examination of receptor glycosylation status, we demonstrate that an entire killer cell immunoglobulin-like receptor (KIR) locus (KIR2DS3)-assumed earlier to be surface expressed-appears to have little appreciable surface expression in transfected cells. This phenotype was noted for receptors encoded by three allelic variants including the common KIR2DS3 *001 allele. Comparing the surface expression of KIR2DS3 with that of the betterstudied KIR2DS1 molecule in two different cell lines, mutational analysis identified multiple polymorphic amino-acid residues that significantly alter the proportion of molecules present on the cell surface. A simultaneous substitution of five residues localized to the leader peptide (residues À18 and À7), second domain (residues 123 and 150) and transmembrane region (residue 234) was required to restore KIR2DS3 to the expression level of KIR2DS1. Corresponding simultaneous substitutions of KIR2DS1 to the KIR2DS3 residues resulted in a dramatically decreased surface expression. Molecular modeling was used to predict how these substitutions contribute to this phenotype. Alterations in receptor surface expression are likely to affect the balance of immune cell signaling impacting the characteristics of the response to pathogens or malignancy.
Introduction
Natural killer (NK) cells are innate immune cells that rely, in part, on a large repertoire of both stimulatory and inhibitory killer cell immunoglobulin-like receptors (KIRs) to determine their activity. 1 The receptor repertoire differs among individuals because multiple KIR haplotypes exist, with each haplotype containing a unique combination of KIR genes. 2 Therefore, an individual will inherit one, two or no copies of a given KIR; this haplotypic diversity appears to result in varied immune responses among individuals. 3 Although several inhibitory KIRs interact with genetically variable epitopes found on certain class I HLA molecules, no strongly interacting ligands have been found for any stimulatory KIR, though they appear to interact weakly with the same HLA recognized by some inhibitory KIR. [4] [5] [6] [7] [8] In several instances, a single extracellular domain aminoacid difference between stimulatory and inhibitory KIR molecules determines the receptor-binding affinity. 6, 9 It is therefore thought that the stimulatory KIRs have an increased affinity for an HLA interface altered slightly under suspicious circumstances, such as an HLA molecule presenting a pathogenic peptide. 10 Despite the structural similarities among KIR family members, minor variations-in many instances single amino-acid changes-between receptors significantly alter the binding specificity and affinity, as well as the amount of receptor expressed on the cell surface. 6, 9, [11] [12] [13] [14] These changes appear to be drastic and widespread among KIRs. For instance, a dozen KIR3DL1 alleles have been described; the receptors encoded by these alleles have been placed into two groups based on either high or low surface expression, whereas one allele is not expressed at all. 15 Furthermore, KIR3DL1 genotype of an individual has been correlated with the progression of HIV infection, based on the surface-expression phenotype of the individual's alleles. 16 Therefore, surface expression changes among KIR molecules may affect the amount of mature receptor available for ligand binding and signaling from the cell surface. Changes in surface expression could easily overwhelm the differences in binding affinity, as greater surface expression may compensate for low receptor affinity.
Earlier we have reported that first domain (D1) polymorphism encoded by the KIR2DL2*004 allele results in the detection of receptor product intracellularly and not at all on the cell surface. 12 The polymorphism responsible for this phenotype (T41) is encoded only by the KIR2DL2*004 allele whereas R41 is encoded by all other KIR receptor variants with a D1 domain. R41 has a homologous amino acid in the second KIR domain (D2) at position 141. R141 is conserved among all KIR variants with a D2 domain, except for receptors encoded by KIR2DS3, which carry T141. We therefore hypothesized that this polymorphism disrupted the surface expression of the KIR2DS3 receptor in the same fashion as the receptor encoded by KIR2DL2*004. Comparing the surface expression of KIR2DS3 with that of the betterstudied KIR2DS1 molecule in two different cell lines, we show that multiple polymorphic amino-acid residues significantly alter the proportion of KIR2DS1 and KIR2DS3 molecules present on the cell surface. These residues are likely critical for either the maturation or stable surface expression of KIR, though the mechanisms behind these processes are as of yet unknown.
Results

KIR2DS3 has reduced surface expression compared with KIR2DS1
To test KIR2DS3 surface expression, receptors were expressed in NKL (NK-cell lineage) and Jurkat (T-cell lineage), two cell lines that lack surface expression of all KIRs. KIR2DS1 was expressed as a positive control as it is a well-characterized stimulatory KIR molecule with a high amino-acid sequence similarity (490%) to KIR2DS3. Although not all T cells express the adaptor DAP12 commonly found associated with surface-expressed stimulatory KIR, 17 earlier studies have shown surface expression of stimulatory KIR in its absence (for example, Campbell et al. 18 and Snyder et al.
19
). Thus, Jurkat was used as a second cell type to test stimulatory KIR surface expression as the mechanism of expression may differ from that of NKL. Cells were cotransfected with GFP and N-terminally FLAG-tagged KIR2DS1 (allele *002) or KIR2DS3 (allele *001) for analysis by flow cytometry. Cells transfected with FLAG-KIR2DS1 could be surface stained with FLAG-specific antibody, whereas cells transfected with FLAG-KIR2DS3 demonstrated that FLAG surface staining was not significantly different from cells transfected with untagged KIR2DS1 or KIR2DS3 (NKL shown in Figure 1a ; Jurkat data not shown). To compare surface staining with total KIR protein, cells were intracellularly stained for a C-terminal V5 tag carried by the N-terminally FLAG-tagged Figure 1 KIR2DS3 is minimally detected on the surface of NKL and Jurkat cells. KIR2DS1 and KIR2DS3 were expressed in NKL and Jurkat cells. (a) Transfectants expressing KIR2DS1 (allele *002) and KIR2DS3 (allele *001) carrying N-terminal FLAG tags were surface stained using anti-FLAG antibody and GFP-positive cells were analyzed by flow cytometry. Transfectants without FLAG tags served as negative controls. NKL (b) and Jurkat (c) cells were transfected with KIR constructs encoding a C-terminal V5 tag in addition to the N-terminal FLAG tag. Cells were surface stained using an anti-FLAG antibody and intracellularly stained using an anti-V5 antibody. Relative surface expression was normalized to FLAG-KIR2DS1 (by Student's t-test vs control: *Po0.05, **Po0.01, ***Po0.001; vs FLAG-KIR2DS1:^^^Po0.001; FLAG-KIR2DS3*001 and FLAG-KIR2DS3*002 vs FLAG-KIR2DS3*004: # Po0.05). In (b), the levels of expression of KIR2DS3 receptors encoded by three allelic variants are compared with KIR2DS1 NKL cells transfected with V5-tagged KIR2DS1 without a FLAG tag, which served as a negative control. (d) C-terminally V5-tagged KIR2DS1, KIR2DS3 or KIR2DL3 was expressed in NKL cells. After the biotinylation of surface proteins, receptors in cell lysates were immunoprecipitated using the anti-V5 antibody and analyzed by gel electrophoresis and western blotting using anti-V5 (for total protein) or streptavidin (for surface-biotinylated protein) probes. (e) NKL cells were transfected with Cterminally V5-tagged KIR2DS1 or KIR2DS3. After staining the plasma membrane with DiO (green stain) and tagged protein with anti-V5 antibody (red stain), the images were merged to determine possible colocalization (shown in yellow). KIR, killer cell immunoglobulin-like receptor.
KIR2DS1 or KIR2DS3. In both NKL and Jurkat cells, staining for FLAG-KIR2DS3 was significantly lower (both Po0.001) than that for FLAG-KIR2DS1 and similar to the negative control (Figures 1b and c) . In both cell lines, the flow cytometry data suggested that very small amounts of KIR2DS3 may be present on the surface of transfected cell.
KIR2DS3 is polymorphic, with multiple alleles encoding at least three distinct receptor proteins (Figure 2 ). 20 Although this study primarily examined the receptor encoded by KIR2DS3*001, the most frequent allele in European Americans, 21 the KIR2DS3*001 construct was mutated to create constructs for KIR2DS3*002 14 and KIR2DS3*004 (CK Hurley, personal communication). 20 When expressed in NKL cells, the receptors encoded by all the three KIR2DS3 alleles demonstrated low levels of surface expression compared with KIR2DS1 (Figure 1b) , though the receptor encoded by KIR2DS3*004 had significantly increased (Po0.05) surface levels compared with the receptors encoded by the other two variants.
To further demonstrate the surface expression differences between KIR2DS1 and KIR2DS3, NKL cells transiently expressing KIR2DS1, KIR2DS3 or the inhibitory KIR2DL3 were surface biotinylated and V5-tagged KIRs were detected by gel electrophoresis and western blotting. Different banding patterns were observed for KIR2DS1, KIR2DS3 and KIR2DL3 (Figure 1d ). KIR2DL3 was detected primarily as a diffuse band at B60 kDa. KIR2DS1 was detected as a diffuse band at B55 kDa and a sharper band of B45 kDa. In both cases, probing for biotin detected only the higher molecular mass forms of KIR2DL3 and KIR2DS1, suggesting that only these isoforms were present at the cell surface. A similar analysis of total KIR2DS3 protein detected only a single band at B40 kDa. Probing for biotin did not detect any bands, indicating that the B40 kDa isoform was not significantly present on the cell surface. As KIR2DS3 protein was not tagged with FLAG in this experiment and in the confocal study described below, it is unlikely that the dramatically reduced expression of KIR2DS3 observed by flow cytometry was due to the presence of the extracellular tag. KIR2DS3 appears as a slightly lower band than the low molecular mass isotype of KIR2DS1, though both receptors theoretically contain the same number of amino acids. The molecular mass difference may be due to post-translational modification.
To verify the location of KIR2DS3, NKL cells transfected with C-terminally V5-tagged KIR2DS1 or KIR2DS3 were prepared with a V5-specific stain for confocal fluorescent microscopy. The cells were also stained with DiO to allow visualization of the plasma membrane. KIR2DS1 colocalized with the plasma membrane and could also be visualized inside the cell, though not inside the nucleus (Figure 1e ). KIR2DS3 formed a similar pattern, but did not colocalize with the plasma membrane. These data are consistent with KIR2DS3 being virtually undetectable on the cell surface, whereas KIR2DS1 is present both on the cell surface and inside the cell.
KIR2DS1 and KIR2DS3 isotypes are the result of glycosylation and maturation To demonstrate that the specific bands found for the stimulatory KIR upon gel electrophoresis (Figure 1d ) are differentially glycosylated isotypes of the same core protein, C-terminally V5-tagged KIR2DS1 or KIR2DS3 was expressed in NKL and Jurkat cells. Cell lysates were mock digested or digested with either endoglycosidase H or PNGase F (Figure 3 ). Mature receptor proteins that have undergone post-translational modification in the Golgi apparatus will be resistant to endoglycosidase H digestion, whereas immature proteins that have not reached the Golgi will be susceptible to the same digestion; both forms of the receptor will be susceptible to digestion by PNGase F. The latter cleaves N-glycans entirely, leaving only the O-glycosylated core protein.
In both NKL and Jurkat cell lines, both the higher and lower molecular mass isoforms of KIR2DS1 could be digested with PNGase F to a core protein of B40 kDa ( Figure 3 ). However, only the lower molecular mass isoform was susceptible to endoglycosidase H digestion, suggesting that this was an immature form of KIR2DS1 found in the endoplasmic reticulum. The higher molecular mass isoform was resistant to digestion with endoglycosidase H and likely represented the mature form of KIR2DS1 expressed on the cellular surface. For KIR2DS3, digestion with PNGase F resulted in a B40 kDa band, similar to that of KIR2DS1. The only Figure 2 Comparison of protein sequences of KIR2DS1 and KIR2DS3 identifies amino acids that may impact surface expression. Alignment of some of the allelic products of KIR2DS1 and KIR2DS3. The consensus and allelic KIR sequences were obtained from the IPD-KIR database. 20 An asterisk at the 3 0 -end of the of the KIR2DS3*002 and KIR2DS3*004 allelic products indicates that the sequence is incomplete. KIR, killer cell immunoglobulin-like receptor.
detectable KIR2DS3 isoform was also susceptible to digestion with endoglycosidase H. The fact that no mature form of KIR2DS3 could be found is consistent with the dramatically reduced KIR2DS3 surface expression, as the immature receptor is not expressed on the surface.
Two polymorphisms in the leader peptide significantly decrease KIR surface expression The putative leader peptides of KIR2DS1 and KIR2DS3 are 21 amino acids long and differ at three polymorphic amino-acid positions ( Figure 2 ). To determine whether any of these polymorphisms are individually responsible for the decreased surface expression of KIR2DS3 compared with KIR2DS1, a series of mutants was created. To identify amino-acid residues with a shared impact on the general structure of the two domain stimulatory KIRs, we tested variation in the contexts of KIR2DS1 and KIR2DS3. The N-terminal FLAG-tagged KIR2DS1 mutant constructs were expressed in NKL and Jurkat cells and surface expression was determined using flow cytometry analysis ( Figure 4 ). In NKL, mutating position À18 from threonine (KIR2DS1*002) to methionine (KIR2DS3*001) or position À7 from leucine to tryptophan both resulted in an approximately 50% reduction in the surface expression of KIR2DS1. When KIR2DS1 was expressed in NKL with both leader mutations, receptor surface expression did not decrease below the levels seen when the individual mutations were made alone (Figure 4a ). Leader mutants expressed in Jurkat cells had less impressive differences, with no statistical decrease in surface expression with mutation at position À18 (Figure 4b) . Therefore, the effect of these changes may be specific to cell type, NK cells vs T cells. Furthermore, mutations made to the KIR2DS1 leader peptide did not reduce KIR2DS1 surface expression to the wild-type KIR2DS3 levels observed in NKL or Jurkat cells, strongly suggesting that other polymorphic amino acids outside of the leader region modulate surface expression of these stimulatory KIRs.
It should be noted that the KIR2DS1 mutation replacing threonine at À18 with a methionine creates the KIR2DS1*003 allele ( Figure 2 ). This receptor had a significantly decreased surface expression in NKL when compared with our reference KIR2DS1 receptor encoded by KIR2DS1*002. Thus, KIR2DS1 alleles may encode receptors differentially expressed at the surface of immune cells.
To determine whether changes at polymorphic aminoacid positions impacting KIR2DS1 expression could restore surface KIR2DS3, KIR2DS3 constructs were created with individual and combination mutations at positions À7 and À18. Expression in NKL and Jurkat cells did not result in an increased surface expression compared with KIR2DS3 (Figures 4c and d) , suggesting that mutations made to the KIR2DS3 leader peptide may increase KIR2DS3 surface expression, but only in conjunction with mutations to residues outside of the leader region.
The D2 domain N123S and L150F polymorphisms significantly decrease KIR surface expression The KIR extracellular domains are critical for ligand binding. Polymorphisms in these domains have also been shown to affect the surface expression of KIR2DL2/ KIR2DL3 12 and KIR3DL1. 14 The R141T polymorphism, predicted to impact KIR2DS3 surface expression, is found in the D2 domain. N-terminal FLAG-tagged KIR2DS1 mutant constructs were created to determine whether individual interlocus polymorphisms in these domains (nine in D1 and nine in D2) contribute to the surface expression difference between KIR2DS1 and KIR2DS3 ( Figure 2 ). When these constructs were expressed in NKL and Jurkat cells and analyzed for surface expression, none of the nine D1 domain mutations individually resulted in a decreased KIR2DS1 expression (data not shown). However, for both cell types, the 123(N4S) and 150(L4F) D2 domain mutations resulted in a significantly decreased KIR2DS1 expression ( Figures  5a and b) . Mutation at the other seven polymorphic D2 positions did not result in significantly decreased receptor expression (data not shown). Furthermore, KIR2DS1 containing both of these mutations had significantly lower surface expression than KIR2DS1 containing either mutation individually. In all instances, the KIR2DS1 mutants had significantly greater surface expression than KIR2DS3. Contrary to the prediction made at the beginning of this study, the 141(R4T) mutation did not result in a significant surface expression decrease (data not shown).
To determine whether the polymorphisms at positions 123 and 150 are responsible for the decreased KIR2DS3 expression, these positions were mutated in the KIR2DS3 expression construct to the amino acids present in KIR2DS1. When expressed in NKL and Jurkat cells, the 123(S4N) mutation doubled the receptor surface expression whereas the 150(F4L) mutation did not significantly increase the surface expression compared with KIR2DS3 (Figures 5c and e) . However, receptors with both the 123(S4N) and 150(F4L) mutations had significantly increased surface expression compared with receptors with 123(S4N) alone though the expression level of the double mutant was still less than that of the wild-type KIR2DS1 (Figures 5c and d) . These data further indicate that the surface expression of KIR2DS1 and KIR2DS3 is dependent upon several amino-acid polymorphisms and that the apparent reduced KIR2DS3 surface expression is due to the additive effect of several mutations that cause decreased receptor maturation.
The immature isoform of the KIR2DS1 123(N4S) mutant receptor was found to have a lower molecular mass when compared with KIR2DS1 ( Figure 5f ). As N123 contributes to a potential N-glycosylation motif (AsnXaa-Ser/Thr), it is likely that the loss of N123 results in decreased N-glycosylation when compared with wild-type KIR2DS1. As a weakly staining higher molecular weight form of the KIR2DS1 mutant receptor was observed, N-glycosylation likely occurs at residues other than N123. The decreased intensity of the higher molecular mass band may be due to the loss of N-glycosylation at position 123 in addition to a decrease in the proportion of terminally glycosylated receptors.
As some KIRs have been shown to associate with adaptor molecules as well as other KIRs, it is possible that polymorphisms may disrupt sites required for intermolecular association. Although the X-ray crystal structure for KIR2DS3 has not been solved, a structure is available for KIR2DS2, another stimulatory KIR with a D1-D2 extracellular domain configuration. 7 The locations of the functionally relevant polymorphic residues (N123S and L150F) were examined to determine how they may modulate receptor surface expression (Figures  5g and h) . Interestingly, residues 123 and 150 are exposed on the surface of the protein. No important interactions could be found between these residues and adjacent amino acids. The I234L polymorphism in the transmembrane domain decreases KIR surface expression in NKL cells Beyond the D1 and D2 domains, stimulatory KIR consists of an extracellular stem, a transmembrane region and an intracellular tail. Five polymorphic amino-acid positions in these segments exist between KIR2DS1 and KIR2DS3: one in the stem region, one in the transmembrane region and three in the intracellular tail (Figure 2 ). Mutations at each of these polymorphic positions were made individually to the FLAG-KIR2DS1 construct to determine which might affect receptor surface expression. For all flow cytometry studies, V5-tagged KIR2DS1 without a FLAG tag was used as a negative control. (f) NKL cells were transfected with empty (EV), V5-tagged KIR2DS1 or V5-tagged KIR2DS1 123(N4S) mutant expression vector. Receptors from transfectant lysates were immunoprecipitated with an anti-V5 antibody and analyzed by gel electrophoresis and western blotting using the same anti-V5 antibody as a probe. KIR2DS1 (g) and KIR2DS3 (h) were modeled based on the X-ray crystal structure of KIR2DS2. The residues at positions 123 and 150, which are critical for KIR surface expression, are shown. KIR, killer cell immunoglobulin-like receptor.
Flow cytometry reveals that the KIR2DS1 234(I4L) mutant receptor had a significantly decreased surface expression compared with KIR2DS1 in NKL cells, but not in Jurkat cells (Figures 6a and b, respectively) . None of the other KIR2DS1 mutant receptors demonstrated decreased surface expression. As this study focused on finding polymorphic residues that result in decreased KIR2DS3 surface expression, residues that appear to increase receptor surface levels, 216(E4K) and 269(S4R), were not investigated further. Reverse mutation at position 234 in KIR2DS3(L4I) resulted in a slight yet significant increase in receptor surface expression in NKL but not in Jurkat cells (Figures 6c and d,  respectively) . These data support the role of position 234 in modulating receptor surface expression in NKL cells.
KIR2DS3 surface expression is rescued to KIR2DS1 levels by five mutations in combination
The five mutations found to decrease KIR2DS1 surface expression alter residues located throughout the KIR molecule: two in the leader peptide, two in the D2 domain and one in the transmembrane region. Reverse mutations of KIR2DS3 do not individually increase surface expression, with the exception of 123(S4N) and 234(L4I) (Figures 5c and c) , suggesting that certain mutations may increase surface expression only in concert with other mutations. To determine whether KIR2DS1 and KIR2DS3 surface expression relied primarily on the five identified mutations, N-terminally FLAGtagged KIR2DS1 and KIR2DS3 constructs were made with mutations at multiple sites. Mutations made in combination with KIR2DS1 resulted in much lower levels of KIR2DS1 surface expression, with mutations at the five positions resulting in surface expression levels statistically equal to those of KIR2DS3 in Jurkat cells and approaching KIR2DS3 levels in NKL cells (Figures 7a  and b) .
To determine if these mutations in combination could restore KIR2DS3 surface expression to KIR2DS1 levels, mutant FLAG-KIR2DS3 constructs were created. A KIR2DS3 receptor with three mutations 123(S4N), 150(F4L) and 234(L4I) in the D2 and transmembrane domains had greatly increased surface expression compared with KIR2DS3, though the surface levels did not reach those of KIR2DS1 (Figures 7c and d) . Expression of a KIR2DS3 construct with all five mutations resulted in even greater surface expression, approaching KIR2DS1 levels in NKL cells and reaching statistically equal levels in Jurkat cells (Figures 7c and d) . Therefore, it appears that five polymorphic residues located throughout the KIR molecule together modulate KIR2DS1 and KIR2DS3 surface expression.
Discussion
In this study, we predicted that the R141T polymorphism would cause the KIR2DS3 receptor to be intracellularly retained, analogous to what occurs due to a similar polymorphism (R41T) in the receptor encoded by KIR2DL2*004. Although the KIR2DS3 receptor has a greatly reduced surface expression compared with KIR2DS1, the R141T polymorphism did not contribute to this phenotype. This parallels a similar observation in KIR2DS4 and KIR2DS5 where a contact residue interacting with R41 was altered but the impact on surface expression was not observed (KIR2DS4) or was limited (KIR2DS5). 22 Therefore, in this study, we tested variation in the context of both KIR2DS1 and KIR2DS3 to identify specific residues with a generalized impact on the structure of two domain stimulatory KIRs.
Though the KIR2DS3 receptor was demonstrated to have a significantly decreased surface expression compared with KIR2DS1, flow cytometry analysis was sensitive enough to detect a small amount of KIR2DS3 surface expression compared with negative controls. Given that these studies examined overexpressed receptors, it is difficult to assess the amount of KIR2DS1 and KIR2DS3 surface expression on normal immune cells. Results from these experiments infer that KIR2DS1 has a greater potential for higher surface expression in vivo compared with KIR2DS3. The detection of an immature KIR2DS1 isoform suggests that KIR2DS1 surface expression is bottlenecked when overexpressed. However, the large differential in surface expression between KIR2DS1 and KIR2DS3 indicates that KIR2DS3 may be bottlenecked by the consumption of additional or different factors than those consumed by KIR2DS1. KIR2DS3 also differs in this regard from KIR2DS4 (allele *001) and KIR2DS5 (allele *002), which, like KIR2DS1, are expressed on the cell surface of NKL and Jurkat transfectants. 22 If KIR2DS3 is expressed at the surface in vivo, its levels are expected to be minute.
The leader peptides of KIR2DS1 and KIR2DS3 contain two polymorphic amino acids that affect receptor surface expression: the M(À18) and W(À7) polymorphisms result in decreased receptor surface expression. Figure 7 KIR2DS3 surface expression is greatly increased by five mutations made in combination. NKL (a) and Jurkat (b) cells were transfected with N-terminally FLAG-tagged, C-terminally V5-tagged KIR2DS1, KIR2DS3 or KIR2DS1 mutant construct and relative surface expression was analyzed (vs KIR2DS1 by Student's t-test: *Po0.05, **Po0.01, ***Po0.001; vs KIR2DS3:^Po0.05,^^^Po0.001). NKL (c) and Jurkat (d) cells were transfected with N-terminally FLAG-tagged, C-terminally V5-tagged KIR2DS1, KIR2DS3 or KIR2DS3 mutant construct for flow cytometric analysis of relative surface expression (vs KIR2DS3 by Student's t-test: **Po0.01, ***Po0.001; vs KIR2DS1:^^Po0.01,^^P o0.001). In all instances (a-d), V5-tagged KIR2DS1 without a FLAG tag was used as a negative control. KIR, killer cell immunoglobulinlike receptor.
Polymorphisms in the leader peptide may affect signal recognition and thus decrease the amount of receptor able to mature for transport to the cell surface. These polymorphisms did not result in an altered molecular mass that would be expected to occur if the leader peptide was not cleaved. Polymorphisms in the leader peptide may affect maturation events that occur before leader peptide cleavage. This would be similar to what occurs with the cytotoxic T-lymphocyte antigen 4, in which an allelic variant encodes a polymorphism in the signal peptide resulting in decreased glycosylation and cell surface expression, but cleavage of the signal peptide is not altered. 23 Interestingly, reverse mutations made to the KIR2DS3 leader region require other reverse mutations outside the leader region before any contribution to increased surface expression can be seen. Thus, the leader sequence remains relevant to events downstream of signal peptide recognition.
Two of the critical amino acids identified in this study are located in the D2 domain, whereas none were found in the D1 domain. Single polymorphisms in an aminoterminal external domain have been shown to result in the intracellular retention of two allelic products (those of KIR3DL1*004 (L86) and KIR2DL2*004 (T41)), likely due to the disruption of important KIR folding motifs. In two other stimulatory KIRs, alteration of both residues 111 and 164 in sequestered KIR2DS5 (*001) to the amino acids found in expressed KIR2DS5 (*002) restored cell surface expression. 22 For these residues, molecular modeling predicted disruption of the D2 structure by P111 and S164 residues. In contrast, critical KIR2DS3 D2 domain amino acids do not appear to form intramolecular interactions and may not be critical for extracellular domain integrity. These residues are surface exposed and hydrophobic (L150) or likely N-glycosylated (N123) in wild-type surface-expressed KIR2DS1 and hence may be important for intermolecular interactions of the KIR extracellular domain. Interactions may occur between KIR and chaperone molecules required for KIR folding or maturation, other KIR molecules (dimerization) or adaptor molecules such as DAP12. Disruption of intermolecular interactions may prevent KIR maturation or folding, change the stability of a KIR complex at the cell surface or promote residence in an endosomal compartment. As the functionally relevant amino acids are not localized in one particular region of the D2 domain, it seems unlikely that both could affect the interaction between KIR and a single molecule; it is possible that multiple interactions may be involved. Interestingly, the D2 domain was earlier predicted to contain the interface for KIR dimerization, suggesting that surface-exposed amino-acid residues in the D2 domain may be required for KIR dimerization. 24 Whether dimerization of KIR2DS1 or KIR2DS3 is required for surface expression is unknown.
The 123(N4S) polymorphism presumably results in decreased glycosylation of KIR2DS3 compared with KIR2DS1. Interestingly, the corresponding amino acid in the D2 domain varies among all KIRs, with KIR2DS5*003 and all alleles of KIR2DL1, KIR2DL4, KIR2DL5, KIR2DS1, KIR2DS4, KIR3DL2 and KIR3DL3 encoding for an asparagine. All the other alleles of KIR2DS5 and all alleles of KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS3 and KIR3DL1 encode for a serine. It is uncertain whether the asparagine is N-glycosylated in all KIRs in which it is present or whether its glycosylation imparts a functional difference among the receptors. However, studies of other NK receptors have demonstrated that receptor N-glycosylation can be critical for recognition of their ligand. 25 A recent study 26 demonstrated that receptors with increased glycosylation were more stable at the cell surface due to interaction of the attached sugars with the extracellular glycomatrix; the loss of an N-glycosylation site on KIR2DS3 may cause decreased surface stability.
The 150(L4F) polymorphism switches between two hydrophobic amino acids, although phenylalanine is more bulky than leucine and contains p electrons in its aromatic ring. It appears that this residue is surface exposed, suggesting that it may be a potential site for interaction with another molecule. It may be that the larger F150 residue may sterically hinder such an interaction. F150 is also encoded by all KIR2DL2, KIR2DL3 and KIR2DS2 alleles. As KIR2DL3 existed almost completely in the mature surface-expressed form, it appears that 150(L4F) may affect only stimulatory KIR, or perhaps only KIR2DS3 and KIR2DS1.
One variation in the transmembrane region, I234L, affected receptor surface expression. All stimulatory KIRs encode I234 except KIR2DS3 and KIR2DS5, which encode L234. This residue is immediately adjacent to K233, a charged amino-acid residue shown to be critical for the association of stimulatory KIR with the DAP12 adaptor molecule. 17 Although this site alternates between two similar amino acids, leucine may modify the affinity for DAP12. Earlier studies have shown that KIR2DS2, a structurally similar stimulatory KIR molecule, maintains its interaction with DAP12 even with multiple mutations to residues adjacent to the charged amino acid.
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KIR2DS5 (common allele *002) shares the L234 with KIR2DS3 and is expressed on the cell surface 28 although its levels are reduced compared to KIR2DS1 with I234. 22 It is possible that this change is less tolerated in mutated KIR2DS1 and wild-type KIR2DS3 and KIR2DS5. KIR2DS3 may simply have reduced affinity for DAP12 such that only a small fraction of KIR2DS3 is carried by DAP12 to the cell surface compared with KIR2DS1.
Mechanisms involved in the transport, surface expression and turnover of stimulatory KIR may vary in different cell types that is, NK cells vs T cells. Variation in surface expression was observed for the KIR2DS1 where the substitution of methionine at À18 in the KIR2DS1 leader reduced expression in the NK cell line, NKL, but had no significant impact in the T-cell line, Jurkat. Likewise, in Jurkat, mutation in the DAP12-binding region (KIR2DS1 234(I4L)) did not impact surface levels in contrast to the reduced expression observed in NKL. Jurkat does not express DAP12 yet expresses stimulatory KIR on its cell surfaces; 18 thus, it is likely that NKL and Jurkat cells differentially express molecules important for the surface expression of KIR2DS1 and KIR2DS3. These differences may lead to the differential impact of mutation in Jurkat vs NKL cell lines observed in this study.
Population studies indicate that KIR2DS3 gene frequency is variable among different populations (B30% in Caucasians, 81% in Australian Aborigines and 12% in Chinese Han). 21, 29 It is difficult to predict the exact effect of reduced KIR2DS3 surface expression as a known ligand for KIR2DS3 has not yet been identified.
The proportion of mature KIR2DS3 may be in flux depending on the NK-cell state or the proportion may be fixed, meaning that very little KIR2DS3 is expressed on the cell surface. Perhaps the KIR2DS3 molecule no longer serves a functional purpose, and the lack of evolutionary selection has allowed detrimental polymorphisms to accumulate. On the other hand, the KIR2DS3 receptor may be functional yet best in only a small dose. The answers to these questions depend on the future knowledge of stimulatory KIR ligands and the life cycle of the KIR receptors.
Materials and methods
DNA constructs
Unless otherwise noted, all expression vectors were created from pEF-DEST51 (Invitrogen, Carlsbad, CA, USA) by Gateway Technology (Invitrogen) using the pCR8/GW/TOPO (Invitrogen) entry vector. KIR2DS3*001 cDNA was obtained from Origene Technologies Inc. (Rockville, MD, USA). KIR2DS1*002 and KIR2DL3 cDNA were amplified as described earlier 30 from a normal human peripheral blood cDNA pool obtained from Biochain Institute Inc. (Hayward, CA, USA). To create C-terminally V5-tagged KIR2DS1, KIR2DS3 and KIR2DL3 constructs, the appropriate cDNA was amplified with serine replacing the stop codon using the following primers: 2DS3-F (GCCACC ATGTCGCTCATGGTCATC) and 2DS-R-Tag (TGATGCG TATGACACC), 2DL3-F (GCCACCATGTCGCTCATGG TCGTCAGC) and 2DL3-R-Tag (TGAGGGCTAGCATT TGG), or 2DS1-F (GCCACCATGTCGCTCACGGTCGTC) and 2DS-R-Tag. The N-terminal FLAG-tagged KIR2DS1 and KIR2DS3 constructs were created by site-directed mutagenesis, which inserted nucleotides encoding DYKDDDDK between the regions encoding the leader and D1 domain. Site-directed mutagenesis was performed using QuikChange II (Stratagene, La Jolla, CA, USA) as per the manufacturer's instructions. All DNA constructs were prepared using the HiSpeed Plasmid Maxi Kit (Qiagen, Valencia, CA, USA). The positions of variation within KIR coding regions are based on the IPD-KIR database. 20 Cell lines, culture and gene expression The NKL cell line was a generous gift of Dr Francisco Borrego (NIAID, Rockville, MD, USA). The Jurkat T-cell clone E6-1 was obtained from the American Type Culture Collection (Manassas, VA, USA). Cell culture and gene transfection protocols have been described earlier. 22 Cells were collected 18 h post-transfection, when KIR protein levels are highest in this system.
Confocal microscopy
Cells were fixed and permeabilized 18 h post-transfection with Cytofix/Cytoperm (BD Pharmingen, Franklin Lakes, NJ, USA), blocked with Image-iT FX (Invitrogen) and stained with rabbit polyclonal anti-V5 (eBioscience, San Diego, CA, USA) and Texas Red-conjugated goat anti-rabbit IgG (Invitrogen). Prepared cells were visualized in 35 mm glass-bottom dishes (World Precision Instruments Inc., Sarasota, FL, USA) using a Fluoview FV300 confocal laser scanning unit on an Olympus IX-70 microscope (Olympus Corporation, Center Valley, PA, USA) with a Â 60 1.4 NA PlanApo lens. Excitation light for the green and red images was provided with a blue Argon laser (488 nm) and a green helium-neon laser (543 nm), respectively. The presented images are singleslice images through each cell at approximately the greatest diameter. Laser intensity and detection sensitivity were minimally altered between samples; however, as expression of the tagged protein was transient, microscopy was used solely for protein localization and not used to measure relative levels of protein between samples.
Flow cytometry
Antibodies used for flow cytometry were purified anti-FLAG M2 (Sigma-Aldrich, St Louis, MO, USA) with phycoerythrin-conjugated anti-mouse IgG (Beckman Coulter, Fullerton, CA, USA), fluorescein isothiocyanate-conjugated anti-V5 (Invitrogen) or purified anti-V5 (Invitrogen) pre-incubated with anti-mouse IgG2a conjugated with Alexa Fluor 488 (Invitrogen). When noted, the cells were cotransfected with pmaxFP-Green (Lonza Cologne AG, Cologne, Germany) and gated on the green signal to increase detection sensitivity. For intracellular staining, cells were prepared the same way as described for confocal microscopy staining. Unless otherwise noted, cells were collected 18 h post-transfection and stained at room temperature for 30 min with each antibody. Cells were analyzed on a Becton Dickinson FACSort with FCS Express 2 software (De Novo Software, Thornhill, Canada). To compare relative surface expression, extracellular stain (anti-FLAG) mean fluorescence intensity was divided by the intracellular stain mean fluorescence intensity (anti-V5). These values were normalized to those of either FLAG-KIR2DS1 or FLAG-KIR2DS3 (as shown in each graph); data shown represent transfection performed in triplicate unless otherwise noted. Each experiment was performed at least two times; data shown are representative of these findings. Statistical analysis for differences in expression was performed using Student's unpaired t-tests.
Molecular modeling KIR2DS1 and KIR2DS3 structures were predicted from the X-ray crystal structure of KIR2DS2 (PDB: 1M4K). 7 The details have been described earlier. 22 Images were created using UCSF Chimera. 31 Immunoprecipitation and western blotting NKL or Jurkat cells were transiently transfected with the appropriate construct. Eighteen hours later, 2 Â 10 7 cells were washed in phosphate-buffered saline. If indicated, surface proteins were biotinylated using NHS-LC-Biotin (Pierce Biotechnology Inc., Rockford, IL, USA) as described by Steiner et al. 22 Glycoprotein digestion with either PGNase F (New England Biolabs, Ipswich, MA, USA) or endoglycosidase H (EMD Biosciences, San Diego, CA, USA) has been described. 22 Immunoprecipitation of lysates with anti-V5 antibody (Invitrogen), reduction and denaturation of the sample, gel electrophoresis on 4-15% polyacrylamide Tris-HCl ready gels (Bio-Rad, Hercules, CA, USA) and blotting protocols have been described. 22 For detection of proteins with a V5 tag, a 1/5000 dilution of anti-V5 antibody (Invitrogen) was used with a 1/20 000 dilution of secondary antibody directed against the mouse heavy and light chains (Jackson Immunoresearch, West Grove, PA, USA). For the detection of immunoprecipitated V5-tagged proteins, a 1/20 000 dilution of secondary antibody directed against the mouse k light chain (Serotec, Oxford, UK) was used. For the detection of biotinylated proteins, a 1/1000 streptavidin-horseradish peroxidase (Amersham Biosciences, Piscataway, NJ, USA) was used. Protein bands were detected using enhanced chemiluminescent detection (Amersham Biosciences).
